Rudy A. Mazzocchi

Last updated
Rudy A. Mazzocchi
Rudy Mazzocchi.jpg
Rudy A. Mazzocchi
Alma mater University of Pittsburgh, UCLA
OccupationExecutive Chairman of ONE Exchange AG, Chairman/CEO of AGENTIX Corp., and Chairman/CEO of ASEP Medical, Inc.
Known forFounding CEO of MICROVENA, Vascular Science, CytoGenesis, and Image-Guided Neurologics.
Awards Ernst & Young Entrepreneur of the Year and Global Entrepreneur of the Year Award by the Business International Group.[31]

Rudy A. Mazzocchi was an American entrepreneur and author. Mazzocchi founded and exited several companies in the med-tech industry including MICROVENA, Vascular Science, Inc., CytoGenesis, Inc. and Image-Guided Neurologics. At his death in 2022, he was Executive Chairman of ONE Exchange AG, Chairman/CEO of AGENTIX Corp., Chairman/CEO of ASEP Medical and former Founding CEO of ELENZA, Executive Chairman of Establishment Labs (NASDAQ:ELSA), Founding Chairman of OptiStent, Inc. and Independent Director of several public and private companies. In 2012, Mazzocchi published the award-winning novel Equity of Evil, the first book of The EQUITY Series. He was the author of over 110 patents. He also served as churchwarden at Manhattan's Little Church Around the Corner. [1]

Contents


Early life

Mazzocchi attended the University of Pittsburgh, graduating with a Bachelor of Science in Life Sciences and Biochemistry. He then completed graduate studies in Biophysics at UCLA. [2]

Entrepreneurship

Mazzocchi's first medical start-up was the firm MICROVENA, a producer of medical devices he founded in 1989 as a co-venture with Phillips Plastics. Soon after its founding MICROVENA began operating independently of Phillips, and within four years had over seven million dollars in annual sales. [3] In 1997 groundwork for a potential Microvena IPO led Piper Jaffray to determine that the value of MICROVENA was between $170 million to $185 million. That year Mazzocchi received the inaugural "technology leader" award from Minnesota Technology Inc. [4] Mazzocchi remained CEO until 1998, [5] after which Mazzocchi joined a lawsuit launched by minority shareholders against the majority owners for opting against company expansion and growth into new areas. [4]

While operating MICROVENA, Mazzocchi co-founded the medical company Vascular Science, Inc, where he served on the board of directors. [6] In 1999 the company was sold to St. Jude Medical, in a deal worth $100 million (including $20 million in milestone payments). [7] He next co-founded and served as a director for CytoGenesis, Inc., which was purchased by BresaGen Ltd in 2000. Mazzocchi also co-founded Quasm Inc., and German-based ReStent Therapeutics, Inc. [8] [9] Mazzocchi joined Image-Guided Neurologics, founded by two U of MN physicians and their investors, serving as CEO and president of the firm [10] until the company was purchased by Medtronic, Inc. in 2005. [11] In 2004 Mazzocchi was asked to take the chairmanship of the public company BresaGen when it entered financial trouble. [12] BresaGen was acquired by Hospira Inc for $17.1 million in 2006. [13] Following this he had been chairman and interim CEO of nanotechnology firm Triton BioSystem and then Managing Director for the Atlanta venture capital company Accuitive Medical Ventures. In 2008 Mazzocchi became CEO of NovaVision. [14] Then in 2010 he was named CEO of Elenza. [15] The company is developing the first auto-focusing intraocular lens replacements for people with cataracts and presbyopia. As of 2015, Elenza was in litigation proceedings against Novartis in relation to its technologies. [16] He was also on the Board of Directors of Greatbatch, serving on the Technology Development and Innovation and Corporate Governance and Nominating committees, [17] and has served as a Director of NexGen Medical Systems. [18]

Books

Mazzocchi published the novel Equity of Evil, the first book of The EQUITY Series, medical thrillers based on true events. [19] The book drew off Mazzocchi's experience in medical venture capitalism and was awarded the Global eBook Award for best suspense novel and an eLit award for best suspense/thriller novel. [20] In a 2012 interview with the Seattle Post-Intelligencer , Mazzocchi wrote of the prologue that it "is actually a snap-shot of my work experience in a human genetics lab during my college years as a pre-med student. We were forbidden from discussing what happened there behind those closed doors and it took nearly 30 years for me to eventually 'tell the story'". [21] The book itself is about a new method of abortion that resulted in the pirating of intact human fetuses that became a supply of harvested organs that were grown like hydroponic vegetables to supply the multi-billion dollar black market of human organ transplants. [22]

Mazzochi's follow-up novel Equity of Fear was released in 2013 by Twilight Times Books. [23] Broadway World Books stated that Equity of Fear offered "the same suspense, intensity and international intrigue" as the first installment of the series. [24]

In late 2013, Mazzocchi then released his first non-fiction book STORYTELLING - The Indispensable Art of Entrepreneurism, also published by Twilight Times Books. [25]

Patents

Mazzocchi authored more than 110 patents, including patents in the fields of cardiology, oncology, orthopedics, neurosurgery, ophthalmology and embryonic stem-cell development. [6] [21] For a few brief examples, in 2001 Mazzocchi was a part of the team that patented a new medical grafting apparatus, granted to St. Jude Medical. [26] In 2003 Mazzocchi authored a patent for a method and apparatus for occluding aneurysms, assigned to AGA Medical Corporation. [27] In 2010 he authored patents for a fiducial marker devices, tools, and methods (awarded to Medtronic, Inc.) [28] and a method and device for filtering body fluid (awarded to ev3 Inc). [29] In 2011 Mazzocchi was named as one of the three inventors of a trajectory guide with angled/patterned guide lumens, given to the University of South Florida. [30]

Awards

Mazzocchi was the recipient of the 2004 Ernst & Young annual Entrepreneur of the Year Award, [31] and received the 2013 Global Entrepreneur of the Year Award by the Business International Group. [32]

Related Research Articles

Wilson Greatbatch was an American engineer and pioneering inventor. He held more than 325 patents and was a member of the National Inventors Hall of Fame and a recipient of the Lemelson–MIT Prize and the National Medal of Technology and Innovation (1990).

<span class="mw-page-title-main">Medtronic</span> Irish tax-registered medical device company

Medtronic plc is an American medical device company based in Ireland for tax purposes. The company primarily operates in the United States. Medtronic has an operational and executive headquarters in Minneapolis, Minnesota in the US. In 2015, Medtronic acquired Irish–tax registered Covidien, in the largest U.S. corporate tax inversion in history, which enabled Medtronic to move its legal registration from the U.S. to Ireland. Medtronic operates in 140 countries and employs over 90,000 people.

<span class="mw-page-title-main">Michael J. Saylor</span> American entrepreneur and business executive

Michael J. Saylor is an American entrepreneur and business executive. He is the executive chairman and a co-founder of MicroStrategy, a company that provides business intelligence, mobile software, and cloud-based services. Saylor served as MicroStrategy's chief executive officer from 1989 to 2022. He authored the 2012 book The Mobile Wave: How Mobile Intelligence Will Change Everything. He is also the sole trustee of Saylor Academy, a provider of free online education. As of 2016, Saylor has been granted 31 patents and has 9 additional applications under review.

<span class="mw-page-title-main">Alfred E. Mann</span> American businessman

Alfred E. Mann, also known as Al Mann, was an American physicist, inventor, entrepreneur, and philanthropist.

<span class="mw-page-title-main">Anthony Adducci</span> Inventor and entrepreneur

Anthony J. Adducci was a pioneer of the medical device industry in Minnesota. He is best known for co-founding Cardiac Pacemakers, Inc., the company that manufactured the world's first lithium battery powered artificial pacemaker. The lithium-iodide cell revolutionized the medical industry and is now the standard cell for pacemakers.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Henry Arnold Klyce, Jr. is an American serial entrepreneur who has founded, or co-founded, four successful medical device companies.

<span class="mw-page-title-main">Arthur D. Collins Jr.</span>

Arthur D. Collins Jr. is an American executive, the retired chairman of the board of Medtronic, Inc., and formerly served the company as president and chief executive officer. He is now a senior advisor to Oak Hill Capital Partners and a managing partner at Acorn Advisors, LLC. Collins is also the author of the children's book series The Adventures of Archibald and Jockabeb.

<span class="mw-page-title-main">Douglas G. Bergeron</span>

Doug Bergeron is the co-managing partner of Hudson Executive Capital (HEC), an event-driven hedge fund focused on improving value and performance in small and mid-cap public and private companies. HEC was founded in 2015 by Douglas Braunstein, former CFO and Vice Chairman of JP Morgan Chase. HEC manages over $2 billion of assets.

<span class="mw-page-title-main">Robert Pittman (media executive)</span> American businessman

Robert Warren Pittman is an American businessman. Pittman was the CEO of MTV Networks and the cofounder and programmer who led the team that created MTV, and is the cofounder of iHeartMedia and Casa Dragones Tequila. Pittman joined iHeartMedia's predecessor company Clear Channel in November 2010 as an investor and the company's Chairman of Media and Entertainment Platforms, was named CEO in 2011 and chairman in 2013. Pittman led Clear Channel's transformation into iHeartMedia, Inc. in September 2014 to reflect its new multiplatform business and expanded mission. Pittman has also been the former chairman and CEO of Clear Channel Outdoor, CEO of AOL Networks, Six Flags Theme Parks, Quantum Media, Century 21 Real Estate and Time Warner Enterprises, and COO of America Online, Inc. and AOL Time Warner.

Neal Creighton is an American entrepreneur based in Boston, Massachusetts, United States. He was one of the co-founders and CEO of certificate authority GeoTrust in 2001, and is co-inventor of the domain-validated certificate patent issued in 2006 which method accounts for 70 percent of all SSL certificates on the Internet. In 2006, GeoTrust was the 2nd largest certificate authority in the world with 26.7 percent market share according to independent survey company Netcraft. He was also cofounder of RatePoint, Inc., which was named the MITX 2010 Social Media Company of the Year for New England.

<span class="mw-page-title-main">Brenton G. Hayden</span> American entrepreneur (born 2010)

Brenton G. Hayden is an American entrepreneur. He is most well known for founding and serving as chief executive officer of Renters Warehouse. Hayden founded Renters Warehouse during the real estate market downturn in 2007. In 2015, the company reported revenues of $15 million, up 184 percent from the last three years.

Stephen Messer is an American Internet entrepreneur, inventor and investor who has founded several global businesses, most notably LinkShare and Collective[i]. Messer served as LinkShare's CEO and chairman of the board, helping to create the sector of online marketing commonly referred to as affiliate marketing. Under his leadership, LinkShare expanded its network of websites to become one of the largest of its kind with its global reach extending from the United States to Japan, Canada and Europe. Messer was a board member of both LinkShare and LinkShare Japan until 2006.

<span class="mw-page-title-main">Protolabs</span>

Protolabs is a company that provides rapid manufacturing of low-volume 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and short-run production. Markets like medical devices, electronics, appliances, automotive and consumer products use these parts. Protolabs' headquarters and manufacturing facilities are located in Maple Plain, Minnesota. The company also has manufacturing facilities in England, Germany, and Japan.

Daniel Cane is a founder of Blackboard Inc. and CourseInfo LLC. He is currently the CEO and co-founder of Modernizing Medicine.

Michael W. Ferro Jr. is an American businessman and tech entrepreneur, founder of Click Commerce and Higi, as well as several other companies including Merrick Ventures, a Chicago-based private equity firm. From February 2016 to March 2018, he was the non-executive chairman of Tribune Publishing, one of the largest newspaper publishers in the United States.

<span class="mw-page-title-main">Omar Ishrak</span> Bangladeshi-American businessman

Omar S. Ishrak is a Bangladeshi-American business executive, serving as the chairman of the board for Intel, since January 2020. He was previously the CEO and chairman of the board of Medtronic from June 2011 to April 2020, and remained as executive chairman and chairman of its board of directors until December 2020.

<span class="mw-page-title-main">Shlomo Ben-Haim</span> Israeli academic and entrepreneur

Shlomo Ben-Haimis an Israeli-born professor of medicine, a serial entrepreneur specializing in the fields of healthcare and biotech, and a philanthropist. He is the co-founder of Biosense Inc., Spectrum Dynamics LLC., Radiancy Inc., X-Technologies, Impulse Dynamics, InStent Inc., Disc-O-Tech Ltd. and EPD Solutions Ltd. He is the inventor of about 560 patents and patent applications.

<span class="mw-page-title-main">Steven G Arless</span> Canadian entrepreneur (born 1949)

Steven G Arless is a Canadian entrepreneur in the biomedical technology industry. He directed and developed several medical device companies treating cardiovascular disease from inception through major financing and public stock offering, advancing new medical devices from R&D to commercialization and global sales, including CryoCath Technologies, CardioInsight and Resonant Medical. He has served as CEO for a number of companies, most notably CryoCath Technologies, Resonant Medical, and CardioInsight.

References

  1. ↑ https://www.tributearchive.com/obituaries/25748628/rudy-a-mazzocchi
  2. ↑ "FORM 8-K XTANT MEDICAL HOLDINGS, INC". SEC. Retrieved August 25, 2019.
  3. ↑ "MICROVENA ANGEL WINGS ATRIAL SEPTAL DEFECT DEVICE CLINICALS". The Gray Sheet. September 20, 1993. Retrieved January 14, 2013.
  4. 1 2 "Boardroom battle shakes MICROVENA". Minneapolis / St. Paul Business Journal . March 29, 1998. Retrieved January 10, 2013.
  5. ↑ "Microvena ordered to pay Continental $5.9M". Minneapolis / St. Paul Business Journal . March 26, 2000. Retrieved January 10, 2013.
  6. 1 2 Mazzocci, R. A. (May 2017). "How does an inventor find an investor or partner? Raising funds to start a company". Surgery. 161 (5): 1183–1186. doi:10.1016/j.surg.2016.08.022. PMID   28438271.
  7. ↑ "St. Jude completes acquisition of Vascular Science". Minneapolis / St. Paul Business Journal . September 27, 1999. Retrieved January 14, 2013.
  8. ↑ "Rudy A. Mazzocchi". twst.com. TWST. Retrieved 25 August 2019.
  9. ↑ "2013 Entrepreneur of the Year awarded to Med-Tech, Startup CEO". Intelligent HQ. Retrieved 25 August 2019.
  10. ↑ "Ev3 nabs $59 million for growth". Minneapolis / St. Paul Business Journal . November 3, 2002. Retrieved January 14, 2013.
  11. ↑ "MEDTRONIC ACQUIRES IMAGE-GUIDED NEUROLOGICS". fdanews.com. FDANEWS. Retrieved 25 August 2019.
  12. ↑ "BresaGen suspended from trading". The Sydney Morning Herald . January 21, 2004. Retrieved January 10, 2013.
  13. ↑ "Hospira completed the acquisition of BresaGen Limited". CMOCRO. 31 October 2006. Retrieved 25 August 2019.
  14. ↑ "NovaVision names new CEO". South Florida Business Journal . June 16, 2008. Retrieved January 10, 2013.
  15. ↑ "ELENZA Closes $24 Million Series B Financing to Fund Development of New Electronic AutoFocal Intraocular Lens". Globes News Wire. 8 February 2008. Retrieved 25 August 2019.
  16. ↑ "A Look at Premium IOLs". ois.net. Ophthalmology Innovation Summit. Retrieved 25 August 2019.
  17. ↑ "Greatbatch, Inc. Elects Rudy A. Mazzocchi to its Board of Directors". Greatbatch, Inc. Business Wire. 5 December 2012. Retrieved 25 August 2019.
  18. ↑ "Business Leaders". Market Screener. Retrieved 25 August 2019.
  19. ↑ Rudy Mazzocchi (2012). Equity of Evil. Twilight Times Books. ISBN   9781606192375 . Retrieved January 10, 2013.
  20. ↑ Katharine Grayson (November 29, 2012). "Serial med-tech entrepreneur turns thriller author". Minneapolis / St. Paul Business Journal . Retrieved January 10, 2013.
  21. 1 2 Tracee Gleichner (March 15, 2012). "Interview with Rudy A. Mazzochi, Author of Equity of Evil". Seattle Post-Intelligencer . Retrieved January 14, 2013.
  22. ↑ "Chapter excerpt" . Retrieved January 14, 2013.
  23. ↑ Rudy A. Mazzocchi. "Book Excerpt: Equity of Fear". Twilight Times Books. Retrieved April 3, 2013.
  24. ↑ "The EQUITY Series of Business/Medical Thrillers by Rudy Mazzocchi, Climb the Charts". BWWBooksWorld. June 4, 2013. Retrieved October 11, 2013.
  25. ↑ Mazzocchi, Rudy A. (2013). Storytelling: The Indispensable Art of Entrepreneurism. Twilight Times Books, 2013. p. 220. ISBN   9781606190074.
  26. ↑ Official Gazette of the United States Patent and Trademark Office: Patents, Volume 1244, Issue 4. U.S. Department of Commerce, Patent and Trademark Office. 2001. p. 3891. Retrieved January 10, 2013.
  27. ↑ "US Patent #6,506,204" . Retrieved January 17, 2013.
  28. ↑ "Patent #7,787,934". August 31, 2010. Retrieved January 17, 2013.
  29. ↑ "Patent #7,828,816". November 9, 2010. Retrieved January 17, 2013.
  30. ↑ "8/15: Patents". Orlando Sentinel . August 14, 2011. Retrieved January 10, 2013.
  31. ↑ "Two Central Floridians named Entrepreneur of the Year". Orlando Business Journal . June 25, 2004. Retrieved January 10, 2013.
  32. ↑ "Serial Entrepreneur, Rudy Mazzocchi, Receives Global Business Recognition Award as the 2013 Entrepreneur of the Year".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.